The University of Manchester Incubator Company The University of Manchester Incubator Company

topborder
About UMIC
Freedom of Information 3
IDEA EVALUATION PORTAL
Manchester Bioscience Incubator (MBI)
Core Technology Facility (CTF)
North Campus Incubator
One Central Park
Broadstone Knowledge Mill
Biotech Business Support
High Tech Business Support
Events
Jobs
Links
Contact Us
Intranet
video

Valid CSS!

HOME ABOUT UMIC INCUBATOR COMPANIES PARTNERS&ASSOCIATES CONFERENCING BIOTECH BUSINESS UNIT HI TECH BUSINESS UNIT E-NEWSLETTER

Freedom of Information 3Freedom of Information 3

CORE TECHNOLOGY FACILITY LIMITED

FREEDOM OF INFORMATION ACT 2000

PUBLICATION SCHEME

 

empty

INTRODUCTION

1. Legal requirement

1.1 Adopting a publication scheme is a requirement of the Freedom of Information Act 2000. This Act promotes greater openness and accountability across the public sector by requiring all ‘public authorities’ to make information available proactively, through a publication scheme.

1.2 ‘Public authorities’ are defined in the Act and include universities and the act also applies to companies wholly owned by at least two public authorities. The act therefore applies to Core Technology Facility Limited.

2. The Publication Scheme

2.1 A publication scheme is a document which describes the information a public authority publishes, or intends to publish. In this context, ‘publish’ means to make information available, routinely. These descriptions are called ‘classes of information’. The scheme is not a list of the actual publications, because this will change as new material is published or existing material revised. It is, however, the public authority’s commitment to make available the information described.

2.2 A publication scheme must set out the classes, or categories, of information published. It must also make clear how the information described can be accessed and whether or not charges will be made.

3. Who we are

Core Technology Facility Limited is a company whose ultimate parent is the University of Manchester.

The company has never traded and is currently dormant.

4. Accessing information covered by the publication scheme

4.1 The classes of information we publish are described in the second part of the scheme.

4.2 Next to each class we have indicated the manner in which the information described will be available. We have also indicated whether charges apply to material in each class.

4.3 To request information available through our publication scheme please contact:

The Company Secretary

Core Technology Facility Limited

C/O UMIP

The Fairbairn Building

PO Box 88

Manchester

M60 1QD

Tel: 0161 306 8518 or Fax 0161 306 3052

5. What about information not covered by the publication scheme

5.1 From 1 January 2005 information not made available through the publication scheme may be requested.

5.2 Requests will have to be made in writing and the Company will normally have 20 working days to respond. We may charge a fee. We will not be required to release information to which an exemption in the Act legitimately applies.

6. Feedback

6.1 It is important that this publication scheme meets your needs. If you find the scheme difficult to understand, please let us know. We also welcome suggestions as to how our scheme might be improved. Any questions, comments or complaints about this scheme should be sent in writing to the Managing Director at the address in 4.3 above.

6.2 If we are unable to resolve any complaint, you can complain to the Information Commissioner, the independent body who oversees the Freedom of Information Act:

Office of the Information Commissioner

Wycliffe House

Water Lane

Wilmslow

Cheshire

SK9 5AF

7. Further information

7.1 More information about the Freedom of Information Act is available on the Information Commissioner’s website at:

www.informationcommissioner.gov.uk

7.2 Either part or the entire Publication Scheme is available in other formats on request. Other formats include hard copy, Braille and larger print.

8. The main groups of classes of information in the Publication Scheme are:

1. lEGAL FRAMEWORK

2. financial

3. human resources

4. HEALTH AND SAFETY

5. services and facilities

6. research

7. contact details


1. LEGAL FRAMEWORK: How the company was established, how the company stands from the point of view of the law, description of the company’s activities and aims and objectives of the company. Information in this section is also available at Companies House at www.companies-house.gov.uk or Tel: 0870 3333636. Companies House may make a small charge to access the information from their database.

CLASS TITLE

DESCRIPTION

MANNER IN WHICH DOCUMENT IS AVAILABLE TO THE PUBLIC

FEE

1.1 Legal Framework

Memorandum and Articles of Association.

Company Registration Number: 04384086


Date of Incorporation:

28/02/2002

Core Technology Facility Ltd (CTC) is 100% owned Manchester Innovation Holdings Limited which is a wholly owned subsidiary of The University of Manchester

Company Type: Private Limited Company

Nature of Business: Dormant company which has never traded.

Available in hard copy only. Make your request in writing to:

The Company Secretary

Core Technology Facility Limited

C/O UMIP

The Fairbairn Building

PO Box 88

Manchester

M60 1QD

Tel: 0161 306 8518 or Fax 0161 306 3052

None

1.2 Governance Structure

Information includes:

  • Details of the Board of Directors
  • Details of the Company Secretary

Available in hard copy only. Make your request in writing to:

The Company Secretary

Core Technology Facility Limited

C/O UMIP

The Fairbairn Building

PO Box 88

Manchester

M60 1QD

Tel: 0161 306 8518 or Fax 0161 306 3052

None

1.3 Statutory Records

Register of:

  • Directors and Secretaries
  • Members and share ledger
  • Application and allotments of shares
  • Share transfers
  • Mortgages and charges
  • Dividends
  • Directors’ interests
  • Guarantors
  • Debentures
  • Substantial interests
  • Resolutions or agreements to which section 380 of the Companies Act 1985 applies, for example special and extraordinary resolutions

Available in hard copy only. Make your request in writing to:

The Company Secretary

Core Technology Facility Limited

C/O UMIP

The Fairbairn Building

PO Box 88

Manchester

M60 1QD

Tel: 0161 306 8518 or Fax 0161 306 3052

Registered Company Number: 04384086

None

1.4 The Aims and Objectives of the Company

Core Technology Facility is a dormant company which has never traded.

The Company does not currently employ any staff.

To receive further information, please contact us at the address below:

The Company Secretary

Core Technology Facility Limited

C/O UMIP

The Fairbairn Building

PO Box 88

Manchester

M60 1QD

Tel: 0161 306 8518 or Fax 0161 306 3052

Please also refer to Section 6 below – Services and Products

None

2. FINANCIAL: Information on funding bodies, Company’s management of financial resources, Annual accounts, Director’s reports prepared in accordance with the Companies Act, Auditor’s report. Information in this section is also available at Companies House at www.companies-house.gov.uk or Tel: 0870 3333636. Companies House may make a small charge to access the information from their database.

CLASS TITLE

DESCRIPTION

MANNER IN WHICH DOCUMENT IS AVAILABLE TO THE PUBLIC

FEE

2.1 Financial

Directors’ Reports and Financial Statements

Annual Returns

Auditor’s Report

Last accounts made up: 31/07/2003

Next accounts due: 31/05/2005

Last return made up to: 28/02/2004

Next

empty
Current News
Unsubscribe
Current News

Risk Awareness workshop - 18th Sept

divider

Regional Sector Networking Event: Biotech / Healthcare

divider

Welcome to UMIC\'s 2nd e-newsletter!

divider

Northwest business software provider launch online business TV channel

divider

F2G Ltd completes 6.3million financing round to fund preclinical and clinical development

divider

Bionow Network Evening - Tuesday 16 September 2008

divider

Knowledge village scheme on awards shortlist

divider

DxS Announces Appointment of Ron Long as Non-Executive Director

divider

Faculty of Engineering - N8 Centre for Translational Regenerative Medicine: Commercial Director (0.4 fte) wanted.

divider

The University of Manchester and GSK strike new research alliance

divider

Manchester gains funding for 170m Biobank.

divider

UMIC is recruiting a new Caretaker/Building Assistant

divider

Darling meets spin-outs during Manchester visit

divider

Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests

divider

Manchester scientists highlighted for contribution to UK economy

divider

DxS Announces Plans to Expand its Manufacturing Capacity and Award of ISO 13485 certification

divider

TARGETED MOLECULAR DIAGNOSTICS and DxS ANNOUNCE A TIMELY WORKSHOP ON ASSESSING SOLID TUMOR MUTATIONS

divider

Welcome to UMICs first enewsletter!

divider

Stem cell hope for paralysed

divider

UMIC launches commercial drug discovery service for UK life sciences

divider

Mobysoft - SMS for Excellence

divider

UMIC is currently recruiting for a Contracts and Client Liaison Manager

divider

Scientific workshop sets up at Broadstone Mill

divider

Illuminating Research - A bright future ahead as Nanoco sign a distribution agreement with Sigma-Aldrich

divider

DxS and Epigenomics AG enter Into Strategic Cross-Licensing Agreement for the Use of Scorpions Technology

divider

Nanoco Technologies present a flagship example of the UKs ability to transform world-class research into cutting edge business

divider

UMIP Spin-Out Gives Hope to Cancer Patients

divider

empty
Login to UMIC
 
   
  Privacy Policy | Terms & Conditions | Freedom of Information | Freedom of Information | Freedom of Information |

Please contact webmaster@manchester.ac.uk with comments and suggestions